Results 121 to 130 of about 3,690 (153)
Some of the next articles are maybe not open access.
Cefiderocol-associated brown chromaturia
BMJ Case Reports, 2023Cefiderocol is a novel siderophore cephalosporin antibiotic. In the present case report, a woman in her 70s presented with a 1-week history of altered mental status and progressive purulent discharge from a non-healing diabetic foot ulcer on her right heel. MRI of the right foot revealed chronic osteomyelitis of the calcaneum.
Michael Smith, Kap Sum Foong
openaire +2 more sources
Cefiderocol: A Siderophore Cephalosporin
Annals of Pharmacotherapy, 2020Objective: This article reviews the available data on the chemistry, spectrum of activity, pharmacokinetic and pharmacodynamic properties, clinical efficacy, and potential place in therapy of cefiderocol. Data Sources: A literature search through PubMed, Google Scholar, and ClinicalTrials.gov was conducted (2009 to March 2020) using the search terms ...
Rania M. El-Lababidi, John George Rizk
openaire +2 more sources
Rapid cefiderocol NP test for detection of cefiderocol susceptibility/resistance in Enterobacterales
Journal of Antimicrobial Chemotherapy, 2022Abstract Background Cefiderocol is among the latest generation of commercialized antibiotics against a large variety of MDR Gram-negative bacteria including carbapenem-resistant Enterobacterales and non-fermenters such as Pseudomonas aeruginosa and Acinetobacter baumannii.
Patrice Nordmann +3 more
openaire +2 more sources
Cefiderocol: a novel siderophore cephalosporin
Expert Opinion on Investigational Drugs, 2018The emergence of multidrug-resistant bacterial pathogens has led to a global public health emergency and novel therapeutic options and drug-delivery systems are urgently needed. Cefiderocol is a siderophore cephalosporin antibiotic that has recently been developed to combat a variety of bacterial pathogens, including β-lactam- and carbapenem-resistant ...
Justin J, Choi, Matthew W, McCarthy
openaire +2 more sources